
Extracorporeal CO2 Elimination for Acute Exacerbation of Severe COPD Requiring Invasive Mechanical Ventilation: A Randomized Controlled Trial (the X-COPD Trial)
The X-COPD trial tested extracorporeal CO2 removal in COPD patients requiring invasive ventilation. Recruitment stopped at 18 of 192 planned patients. Ventilation duration was shorter with ECCO2R, but death or severe disability at day 60 was not significantly reduced. One ECCO2R patient had severe bleeding. The findings support further research into assisted early extubation, while the small sample, unblinded design, and early termination prevent firm conclusions about clinical benefit or safety.

